Bank of Canada will hold its policy meeting on Wednesday and is widely anticipated to raise interest rates for the first time in seven years, with the move expected to drive interest rates and the Canadian dollar higher.
If the central bank does lift benchmark interest rates, it will become only the second major central bank after the Federal Reserve to tighten the monetary policy.
Meanwhile the European Central Bank is still maintaining a dovish posture, though a recent account of discussions from its meeting policy meetings last month and comments from ECB President Mario Draghi have been read by market participants as hinting at policy makers considering the reduction of accommodative policies in the near term.
stock market usa: EXCO Resources NL(XCO)
Advisors’ Opinion:
- [By Alex McGuire]
These are the 10 best penny stocks that have seen the biggest returns over the last week (March 7 – March 14)…
Penny StockCurrent PriceWeekly Gain (March 7 – March 14)Ocera Therapeutics Inc. (Nasdaq: OCRX)$1.47+147.1%Internap Corp. (Nasdaq: INAP)$3.28+41.4%Soligenix Inc. (Nasdaq: SNGX)$2.94+40%Navios Maritime Partners LP (NYSE: NMM)$2.63+37%QuickLogic Corp. (Nasdaq: QUIK)$2.14+30.5%Adamis Pharmaceuticals Corp. (Nasdaq: ADMP)$4.60+22.7EXCO Resources Inc. (NYSE: XCO)$0.65+20.5%Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC)$4.38+20.3%Hebron Technology Co. Ltd. (Nasdaq: HEBT)$3.99+19.1%Curis Inc. (Nasdaq: CRIS)$2.85+18.4%
As a reminder, this is only a tracking metric of penny stocks trading on SEC-regulated exchanges like the Nasdaq and NYSE. Although these top penny stocks are safer than those trading on the pink sheets, we don’t recommend buying any of them without the proper amount of financial research.
stock market usa: MDC Partners Inc.(MDCA)
Advisors’ Opinion:
- [By Lisa Levin]
MDC Partners Inc (NASDAQ: MDCA) shares dropped 60 percent to $3.38. MDC Partners reported a Q3 loss of $0.64 per share on revenue of $349.3 million.
- [By Lisa Levin]
Shares of MDC Partners Inc (NASDAQ: MDCA) were down 31 percent to $12.52 after the company posted downbeat quarterly results and lowered its FY16 sales outlook.
stock market usa: Aurora Cannabis Inc. (ACBFF)
Advisors’ Opinion:
- [By Javier Hasse]
While biotechs like GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) and Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) only lost 0.45 percent and 0.36 percent respectively, other companies experienced a large tumble. CANOPY GROWTH CORP COM NPV (OTC: TWMJF) lost 4.71 percent, AURORA CANNABIS IN COM NPV (OTC: ACBFF) slipped 2.93 percent, APHRIA INC COM NPV (OTC: APHQF) dropped 1.01 percent, and MassRoots Inc (OTC: MSRT) plummeted an astounding 9.00 percent.
- [By Keith Speights]
As increasingly more marijuana growers entered the market and more states allowed residents to legally grow marijuana, cannabis prices dropped throughout 2016. Wholesale marijuana prices late in the year were roughly half the levels of 12 months earlier. Will this trend continue — and possibly hurt leading marijuana stocks including Aphria (NASDAQOTH:APHQF),Aurora Cannabis (NASDAQOTH:ACBFF), Medical Marijuana,Inc.(NASDAQOTH:MJNA), and even GW Pharmaceuticals (NASDAQ:GWPH) in the process?
- [By Javier Hasse]
Also quite recently, Benzinga asked Alan Brochstein, founding partner at New Cannabis Ventures and founder at 420 Investor, about plays in the marijuana industry against such an uncertain backdrop. The expert mentioned a few Canadian Licensed Producers, including AURORA CANNABIS IN COM NPV (OTC: ACBFF), APHRIA INC NPV (OTC: APHQF), METTRUM HEALTH COR COM NPV (OTC: MQTRF), ORGANIGRAM HLDGS I COM NPV (OTC: OGRMF), SUPREME PHARMACEUT COM NPV (OTC: SPRWF) and CANOPY GROWTH CORP COM NPV (OTC: TWMJF), as well as “the only” biotech stock in the space, GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH).
- [By Sean Williams]
This rapid growth in legal pot has create quite the demand for marijuana stocks. The seven largest marijuana stocks by market cap have all put on a show over the past couple of years. Here are those seven “green giants” listed with their market caps as of March 17, 2017, along with their trailing one-year total returns.
GW Pharmaceuticals (NASDAQ:GWPH): $3.0 billion, up 64% Canopy Growth Corp. (NASDAQOTH:TWMJF): $904 million, up 259% Aphria (NASDAQOTH:APHQF) $440 million, up 381% Aurora Cannabis (NASDAQOTH:ACBFF): $482 million, up 299% AXIM Biotechnologies (NASDAQOTH:AXIM): $562 million, up 1,720% Corbus Pharmaceuticals (NASDAQ:CRBP): $450 million, up 431% Medical Marijuana (NASDAQOTH:MJNA): $221 million, up 254%
As you can see, these are some hefty valuations — and some exceptionally strong moves higher on the heels of marijuana’s expansion. With the exception of GW Pharmaceuticals, every one of the largest marijuana stocks has at least tripled in value over the trailing 12 months, with cannabinoid-based drug developer AXIM Biotechnologies skyrocketing more than 1,700%!
- [By SEEKINGALPHA.COM]
President Trump has threatened to increase enforcement of federal cannabis laws. One might think that this will have a negative impact on marijuana and marijuana related stocks like Aurora Cannabis (OTCQB:ACBFF), General Cannabis (OTCQB:CANN), Americann (OTCQX:ACAN), and MassRoots (OTCQB:MSRT), and if implemented it probably would be devastating, both to publicly traded marijuana companies, and to local companies in regions that have legalized pot.
stock market usa: On Assignment Inc.(ASGN)
Advisors’ Opinion:
- [By Jim Robertson]
On Thursday, our Under the Radar Moversnewslettersuggested suggested small cap employment services stockOn Assignment, Inc (NYSE: ASGN) as a short trade thats already turned profitable for us:
